livn-20200729

0001639691-20-000093.txt : 20200729 0001639691-20-000093.hdr.sgml : 20200729 20200729060509 ACCESSION NUMBER: 0001639691-20-000093 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20200729 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200729 DATE AS OF CHANGE: 20200729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LivaNova PLC CENTRAL INDEX KEY: 0001639691 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 981268150 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37599 FILM NUMBER: 201055615 BUSINESS ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG BUSINESS PHONE: 4402033250662 MAIL ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Plc DATE OF NAME CHANGE: 20150420 FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Ltd DATE OF NAME CHANGE: 20150415 8-K 1 livn-20200729.htm 8-K livn-20200729

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2020

LivaNova PLC

(Exact Name of Registrant as Specified in its Charter)

England and Wales

001-37599

98-1268150

(State or Other Jurisdiction
of Incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

20 Eastbourne Terrace

London, W2 6LG

United Kingdom

(Address of Principal Executive Offices)

+44 20 33250660

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name on each exchange on which registered
Ordinary Shares - £1.00 par value per share	LIVN	NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


			Emerging growth company			☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


						☐

Item 2.02 Results of Operations and Financial Condition.

On July 29, 2020, LivaNova PLC (the “Company”) issued a press release announcing financial results for the second quarter ended June 30, 2020. The Company will host a business update conference call and webcast today, July 29, 2020, at 12 p.m. London time (7 a.m. Eastern Time), during which the Company will discuss the financial results. The conference call will be available to interested parties through a live audio webcast and accessible through the Investor Relations section of the LivaNova corporate website at www.livanova.com. A copy of the Company’s press release is furnished as Exhibit 99.1 on this Current Report on Form 8-K.

The information in Item 2.02 of this report is being furnished, not filed, for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and pursuant to General Instruction B.2 of Form 8-K, will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.

Item 9.01 Financial Statements and Exhibits


Exhibit						Description
99.1						Press Release of LivaNova PLC dated July 29, 2020

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			LivaNova PLC


Date: July 29, 2020			By:/s/ Keyna Skeffington
			Name: Keyna Skeffington
			Title: Senior Vice President & General Counsel

EX-99.1 2 a2q20earningspressrele.htm PRESS RELEASE OF LIVANOVA PLC Document

EXHIBIT 99.1

NEWS RELEASE

LivaNova Reports Second Quarter 2020 Results

London, July 29, 2020 – LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2020.

For the second quarter of 2020, worldwide sales from continuing operations were $182.2 million, a decrease of 34.3 percent on a reported basis and a decline of 33.1 percent on a constant-currency¹ basis, as compared to the same quarter of the previous year. On the basis of U.S. Generally Accepted Accounting Principles (GAAP), second quarter 2020 diluted loss per share from continuing operations was $1.81. Second quarter 2020 adjusted diluted loss per share from continuing operations was $0.15.

"Responding to current conditions, we implemented actions to continue serving our patients, their families and physicians. At the same time, we significantly reduced expenses, improved liquidity and increased financial flexibility. I am proud of our employees' determination in overcoming the challenges created by COVID-19," said Damien McDonald, Chief Executive Officer of LivaNova. "While COVID-19 continues to impact our business, we are encouraged by several trends and achievements, including a gradual improvement in procedure volumes, the full commercial release of LifeSPARC^TM in the U.S. and the launch of Perceval^® Plus in Europe."

¹Constant-currency percent change is considered a non-GAAP metric.

Second Quarter 2020 Results

The following table summarizes worldwide sales for the second quarter of 2020 by business:


$ in millions	Three Months Ended June 30,				% Change		Constant-Currency % Change
Business / Product Line:	2020	2019
Cardiopulmonary	$101.1	$130.6	(22.6	%)	(20.8	%)
Heart Valves	17.5	33.4	(47.6	%)	(46.8	%)
Advanced Circulatory Support	6.0	8.3	(27.7	%)	(27.6	%)
Cardiovascular	124.5	172.2	(27.7	%)	(26.2	%)
Neuromodulation	57.2	104.3	(45.1	%)	(44.7	%)
Other	0.5	0.7	(30.0	%)	(28.5	%)
Total Net Sales	$182.2	$277.2	(34.3	%)	(33.1	%)

•Note: Numbers may not add up precisely due to rounding. Constant-currency percent change is considered a non-GAAP metric.

All sales growth rates below reflect comparable, constant-currency growth. Constant-currency growth accounts for the impact from fluctuations in the various currencies in which the Company operates as compared to reported growth.

Cardiovascular

Cardiovascular sales, which include Cardiopulmonary, Heart Valves and Advanced Circulatory Support (ACS) products, were $124.5 million, representing a 26.2 percent decrease versus the second quarter of 2019.

Sales in Cardiopulmonary products were $101.1 million, representing a 20.8 percent decline versus the second quarter of 2019. For the second quarter of 2020, the sales decrease was related to the impact of COVID-19 on cardiac surgery procedure volumes and a slow-down in capital equipment purchases.

Heart Valve sales were $17.5 million, a decrease of 46.8 percent compared to the second quarter of 2019 due to the impact of COVID-19 on surgical valve replacement procedures.

ACS sales were $6.0 million in the quarter, a decrease of 27.6 percent compared to the second quarter of 2019, as customers delayed purchases in anticipation of the LifeSPARC launch in the third quarter of this year.

Neuromodulation

Neuromodulation sales were $57.2 million in the second quarter, representing a 44.7 percent decrease versus the second quarter of 2019. This decline was primarily related to the impact of COVID-19 on procedure volumes globally.

Financial Performance

On a U.S. GAAP basis, second quarter 2020 operating loss from continuing operations was $15.2 million. Adjusted operating loss from continuing operations for the second quarter of 2020 was $4.2 million, a decrease of 109.5 percent as compared to the second quarter of 2019 related to the revenue impact from COVID-19, partially offset by reductions in discretionary spending.

The adjusted effective tax rate in the quarter was 2.8 percent, as compared to 15.4 percent in the second quarter of 2019 related to changes in the geographic income mix and a partial valuation allowance in the U.S.

On a U.S. GAAP basis, second quarter 2020 diluted loss per share from continuing operations was $1.81. Second quarter 2020 adjusted diluted loss per share from continuing operations was $0.15, versus a gain of $0.70 per share in the second quarter of 2019.

2020 Updated Guidance

LivaNova worldwide net sales for full-year 2020 are still expected to decline between 7 and 17 percent on a constant-currency basis. In the second quarter, we undertook actions to improve our liquidity and refinance our debt. As a result, adjusted diluted earnings per share from continuing operations for 2020 are expected to be in the range of $1.15 to $1.35, which reflects an incremental impact of $0.28 due to these financing activities.

Webcast and Conference Call Instructions

The Company will host a live audio webcast for interested parties commencing at 12 p.m. London time (7 a.m. Eastern Time) on Wednesday, July 29 that will be accessible through the Investor Relations section of the LivaNova corporate website at www.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. To listen to the conference call by telephone, dial 844-239-5285 (if dialing from within the U.S. or Canada) or 512-961-6524 (if dialing from outside the U.S. or Canada). The conference ID is 9894538. Within 24 hours of the webcast, a replay will be available under the "News & Events / Presentations" section of the Investor Relations portion of the LivaNova website, where it will be archived and accessible for approximately 90 days.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. LivaNova operates as two businesses: Cardiovascular and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston (U.S.), respectively.

For more information, please visit www.livanova.com.

Use of Non-GAAP Financial Measures

In this press release, management has disclosed financial measurements that present financial information not necessarily in accordance with GAAP. Company management uses these measurements as aids in monitoring the Company’s ongoing financial performance from quarter to quarter and year to year on a regular basis and for benchmarking against other medical technology companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP.

Unless otherwise noted, all sales growth rates in this release reflect comparable, constant-currency growth. Management believes that referring to comparable, constant-currency growth is the most useful way to evaluate the sales performance of LivaNova and to compare the sales performance of current periods to prior periods on a consistent basis. Constant-currency growth, a non-GAAP financial measure, measures the change in sales between current and prior-year periods using average exchange rates in effect during the applicable prior-year period.

LivaNova calculates forward-looking non-GAAP financial measures based on internal forecasts that omit certain amounts that would be included in GAAP financial measures. For example, forward-looking net sales growth projections are estimated on a constant-currency basis and exclude the impact of foreign currency fluctuations. Forward-looking non-GAAP adjusted tax rate and adjusted diluted earnings per share guidance exclude other items such as, but not limited to, changes in fair value of contingent consideration arrangements, asset impairment charges and product remediation costs that would be included in comparable GAAP financial measures. The most directly comparable GAAP measure for constant-currency net sales, non-GAAP adjusted tax rate and adjusted diluted earnings per share are net sales, the effective tax rate, and earnings per share, respectively. However, non-GAAP financial adjustments on a forward-looking basis are subject to uncertainty and variability as they are dependent on many factors, including but not limited to, the effect of foreign currency exchange fluctuations, impacts from potential acquisitions or divestitures, gains or losses on the potential sale of businesses or other assets, restructuring costs, merger and integration activities, changes in fair value of contingent consideration arrangements, product remediation costs, asset impairment charges, and the tax impact of the aforementioned items, tax law changes or other tax matters. Accordingly, reconciliations to the most directly comparable forward-looking GAAP financial measures are not available without unreasonable effort.

The Company also believes adjusted financial measures such as adjusted gross profit percentage; adjusted selling, general and administrative expense; adjusted research and development expense; adjusted other operating expenses; adjusted operating income from continuing operations; adjusted income tax expense; adjusted net income from continuing operations; and adjusted diluted earnings per share from continuing operations, are measures by which LivaNova generally uses to facilitate management review of the operational performance of the company, to serve as a basis for strategic planning, and to assist in the design of compensation incentive plans. Furthermore, adjusted financial measures allow investors to evaluate the Company’s core performance for different periods on a more comparable and consistent basis, and with other entities in the medical technology industry by adjusting for items that are not related to the ongoing operations of the Company or incurred in the ordinary course of business.

Safe Harbor Statement

Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, LivaNova’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve

known and unknown risks that are difficult to predict. As a result, our actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee,” or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by LivaNova and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning achieving a stronger future, driving sustainable growth and value to our shareholders, projected net sales, adjusted diluted earnings per share, cash flow from operations, capital expenditures, and depreciation and amortization for 2020, advancing our growth, driving product launches and funding our equity investments, executing on our synergy targets and retaining our focus, energy and discipline as a company, and serving the needs of our customers and patients. Important factors that may cause actual results to differ include, but are not limited to: (i) the severity and duration of the COVID-19 pandemic and its impact on our business, financial condition and results of operations; (ii) reductions in customer spending, a slowdown in customer payments and changes in customer demand for products and services; (iii) unanticipated changes relating to competitive factors in the industries in which LivaNova operates; (iv) the ability to hire and retain key personnel; (v) the ability to attract new customers and retain existing customers in the manner anticipated; (vi) changes in legislation or governmental regulations affecting LivaNova; (vii) international, national or local economic, social or political conditions that could adversely affect LivaNova, its partners or its customers; (viii) conditions in the credit markets; (ix) business and other financial risks inherent to the industries in which LivaNova operates; (x) risks associated with assumptions made in connection with critical accounting estimates and legal proceedings; (xi) LivaNova’s international operations, which are subject to the risks of currency fluctuations and foreign exchange controls; (xii) the potential for international unrest, economic downturn or effects of currencies, tax assessments, tax adjustments, anticipated tax rates, raw material costs or availability, benefit or retirement plan costs, or other regulatory compliance costs; (xiii) the inability of LivaNova to meet expectations regarding the timing, completion and accounting of tax treatments; (xiv) and organizational and governance structure. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties that affect the Company’s business, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other documents filed from time to time with the United States Securities and Exchange Commission by LivaNova.

We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. The Company does not undertake or assume any obligation to update publicly any of the forward-looking statements in this press release to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.


Melissa Farina Vice President, Investor Relations  Phone: +1 (281) 228 7262  e-mail: investorrelations@LivaNova.com


LIVANOVA PLC
NET SALES
(U.S. dollars in millions)
		Three Months Ended June 30,
		2020		2019		% Change at Actual Currency Rates			% Change at Constant-Currency Rates⁽¹⁾
Cardiopulmonary
US			$25.8		$41.4		(37.6)	%		(37.6)	%
Europe			23.3		34.3		(32.1)	%		(30.7)	%
Rest of World			51.9		54.9		(5.3)	%		(1.9)	%
Total			101.1		130.6		(22.6)	%		(20.8)	%
Heart Valves
US			2.5		4.7		(46.8)	%		(46.8)	%
Europe			5.3		10.7		(49.9)	%		(49.1)	%
Rest of World			9.6		18.0		(46.5)	%		(45.4)	%
Total			17.5		33.4		(47.6)	%		(46.8)	%
Advanced Circulatory Support
US			5.7		7.9		(28.7)	%		(28.7)	%
Europe			0.3		0.2		N/A			N/A
Rest of World			—		0.2		N/A			N/A
Total			6.0		8.3		(27.7)	%		(27.6)	%
Cardiovascular
US			34.0		54.0		(37.1)	%		(37.1)	%
Europe			28.9		45.2		(35.9)	%		(34.7)	%
Rest of World			61.6		73.0		(15.6)	%		(12.8)	%
Total			124.5		172.2		(27.7)	%		(26.2)	%
Neuromodulation
US			44.2		80.6		(45.1)	%		(45.1)	%
Europe			6.4		13.0		(50.6)	%		(49.3)	%
Rest of World			6.6		10.7		(38.6)	%		(36.2)	%
Total			57.2		104.3		(45.1)	%		(44.7)	%
Other
US			—		—		N/A			N/A
Europe			—		—		N/A			N/A
Rest of World			0.5		0.7		(30.0)	%		(28.5)	%
Total			0.5		0.7		(30.0)	%		(28.5)	%
Totals
US			78.2		134.6		(41.9)	%		(41.9)	%
Europe			35.4		58.2		(39.2)	%		(37.9)	%
Rest of World			68.7		84.4		(18.7)	%		(15.9)	%
Total			$182.2		$277.2		(34.3)	%		(33.1)	%

(1)	Constant-currency growth, a non-GAAP financial measure, measures the change in sales between current and prior-year periods using average exchange rates in effect during the applicable prior-year period.
*	The sales results presented are unaudited. Numbers may not add up precisely due to rounding.


LIVANOVA PLC
NET SALES
(U.S. dollars in millions)
		Six Months Ended June 30,
		2020		2019		% Change at Actual Currency Rates			% Change at Constant-Currency Rates ⁽¹⁾
Cardiopulmonary
US			$62.7		$80.5		(22.2)	%		(22.2)	%
Europe			57.5		69.9		(17.7)	%		(15.5)	%
Rest of World			97.2		101.7		(4.4)	%		(1.2)	%
Total			217.4		252.1		(13.8)	%		(11.9)	%
Heart Valves
US			5.9		9.0		(35.1)	%		(35.1)	%
Europe			14.9		21.2		(29.8)	%		(28.1)	%
Rest of World			21.9		28.8		(23.8)	%		(22.0)	%
Total			42.7		59.0		(27.7)	%		(26.2)	%
Advanced Circulatory Support
US			15.7		16.0		(1.5)	%		(1.5)	%
Europe			0.7		0.3		N/A			N/A
Rest of World			0.1		0.3		N/A			N/A
Total			16.5		16.6		(0.4)	%		(0.3)	%
Cardiovascular
US			84.3		105.5		(20.1)	%		(20.1)	%
Europe			73.1		91.4		(20.0)	%		(18.0)	%
Rest of World			119.2		130.8		(8.8)	%		(5.9)	%
Total			276.6		327.7		(15.6)	%		(13.9)	%
Neuromodulation
US			117.5		157.4		(25.4)	%		(25.4)	%
Europe			17.0		23.7		(28.1)	%		(25.9)	%
Rest of World			12.4		17.8		(30.6)	%		(27.3)	%
Total			146.9		198.9		(26.2)	%		(25.6)	%
Other
US			—		—		N/A			N/A
Europe			—		—		N/A			N/A
Rest of World			1.1		1.3		(14.2)	%		(12.0)	%
Total			1.1		1.3		(14.2)	%		(12.0)	%
Totals
US			201.8		263.0		(23.3)	%		(23.3)	%
Europe			90.1		115.0		(21.7)	%		(19.6)	%
Rest of World			132.8		150.0		(11.5)	%		(8.5)	%
Total			$424.6		$528.0		(19.6)	%		(18.3)	%

(1)	Constant-currency growth, a non-GAAP financial measure, measures the change in sales between current and prior-year periods using average exchange rates in effect during the applicable prior-year period.
*	The sales results presented are unaudited. Numbers may not add up precisely due to rounding.


LIVANOVA PLC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - UNAUDITED
(U.S. dollars in millions, except per share amounts)

	Three Months Ended June 30,
	2020	2019	% Change
Net sales	$182.2	$277.2
Costs and expenses:
Cost of sales - exclusive of amortization	56.8	74.9
Product remediation	4.3	5.1
Selling, general and administrative	98.0	127.2
Research and development	25.2	34.5
Merger and integration expenses	2.0	4.4
Restructuring expenses	0.8	1.3
Impairment of intangible assets	—	50.3
Amortization of intangibles	9.4	9.2
Litigation provision, net	1.0	—
Operating loss from continuing operations	(15.2)	(29.9)	(49.2	%)
Interest expense, net	(5.4)	(3.8)
Foreign exchange and other losses	(1.0)	(1.9)
Loss from continuing operations before tax	(21.7)	(35.6)	(39.0	%)
Income tax expense (benefit)	66.3	(6.2)

Net loss from continuing operations	(88.0)	(29.4)	199.3	%
Net income from discontinued operations, net of tax	—	0.2
Net loss	($88.0)	($29.2)	201.4	%

Basic loss per share:
Continuing operations	($1.81)	($0.61)
Discontinued operations	—	0.01
	($1.81)	($0.60)

Diluted loss per share:
Continuing operations	($1.81)	($0.61)
Discontinued operations	—	0.01
	($1.81)	($0.60)

Weighted average common shares outstanding:
Basic	48.6	48.3
Diluted	48.6	48.3

* Numbers may not add up precisely due to rounding.


Adjusted Financial Measures (U.S. dollars in millions, except per share amounts)

		Three Months Ended June 30,
		2020		2019		% Change ⁽¹⁾
Adjusted SG&A ⁽¹⁾			$79.7		$108.1		(26.3	%)
Adjusted R&D ⁽¹⁾			35.2		39.7		(11.3	%)
Adjusted operating (loss) income from continuing operations ⁽¹⁾			(4.2)		44.2		(109.5	%)
Adjusted net (loss) income from continuing operations ⁽¹⁾			(7.5)		34.3		(121.9	%)
Adjusted diluted (loss) earnings per share from continuing operations ⁽¹⁾			($0.15)		$0.70		(121.4	%)

(1)	Adjusted financial measures are non-GAAP measures and exclude specified items as described and reconciled in the "Reconciliation of GAAP to non-GAAP Financial Measures" contained in the press release.


Statistics (as a % of net sales, except for income tax rate)

		GAAP Three Months Ended June 30,									Adjusted ⁽¹⁾ Three Months Ended June 30,
		2020			2019			2020			2019
Gross profit			66.5	%		71.1	%		60.7	%		69.3	%
SG&A			53.8	%		45.9	%		43.7	%		39.0	%
R&D			13.8	%		12.5	%		19.3	%		14.3	%
Operating (loss) income from continuing operations			(8.4	%)		(10.8	%)		(2.3	%)		15.9	%
Net (loss) income from continuing operations			(48.3	%)		(10.6	%)		(4.1	%)		12.4	%
Income tax rate			(306.0	%)		17.3	%		2.8	%		15.4	%

(1)	Adjusted financial measures are non-GAAP measures and exclude specified items as described and reconciled in the "Reconciliation of GAAP to non-GAAP Financial Measures" contained in the press release.


LIVANOVA PLC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - UNAUDITED
(U.S. dollars in millions, except per share amounts)

	Six Months Ended June 30,
	2020	2019	% Change
Net sales	$424.6	$528.0
Costs and expenses:
Cost of sales - exclusive of amortization	125.7	159.2
Product remediation	5.7	8.1
Selling, general and administrative	218.2	252.9
Research and development	61.1	78.1
Merger and integration expenses	5.5	7.6
Restructuring expenses	2.4	3.9
Impairment of intangible assets	—	50.3
Amortization of intangibles	19.7	18.5
Litigation provision, net	1.0	—
Operating loss from continuing operations	(14.6)	(50.7)	(71.2	%)
Interest expense, net	(10.1)	(5.2)
Foreign exchange and other losses	(2.9)	(1.1)
Loss from continuing operations before tax	(27.7)	(57.0)	(51.4	%)
Income tax expense (benefit)	21.6	(12.8)
Losses from equity method investments	(0.2)	—
Net loss from continuing operations	(49.4)	(44.2)	11.8	%
Net (loss) income from discontinued operations, net of tax	(1.0)	0.2
Net loss	($50.4)	($44.1)	14.3	%

Basic loss per share:
Continuing operations	($1.02)	($0.92)
Discontinued operations	(0.02)	0.01
	($1.04)	($0.91)

Diluted loss per share:
Continuing operations	($1.02)	($0.92)
Discontinued operations	(0.02)	0.01
	($1.04)	($0.91)

Weighted average common shares outstanding:
Basic	48.5	48.3
Diluted	48.5	48.3

* Numbers may not add up precisely due to rounding.


Adjusted Financial Measures (U.S. dollars in millions, except per share amounts)

		Six Months Ended June 30,
		2020		2019		% Change ⁽¹⁾
Adjusted SG&A ⁽¹⁾			$183.4		$212.6		(13.7	%)
Adjusted R&D ⁽¹⁾			76.1		76.5		(0.5	%)
Adjusted operating income from continuing operations ⁽¹⁾			16.8		76.6		(78.1	%)
Adjusted net income from continuing operations ⁽¹⁾			8.5		60.9		(86.0	%)
Adjusted diluted earnings per share from continuing operations ⁽¹⁾			$0.17		$1.25		(86.4	%)

(1)	Adjusted financial measures are non-GAAP measures and exclude specified items as described and reconciled in the "Reconciliation of GAAP to non-GAAP Financial Measures" contained in the press release.


Statistics (as a % of net sales, except for income tax rate)

		GAAP Six Months Ended June 30,									Adjusted ⁽¹⁾ Six Months Ended June 30,
		2020			2019			2020			2019
Gross profit			69.0	%		68.3	%		65.1	%		69.3	%
SG&A			51.4	%		47.9	%		43.2	%		40.3	%
R&D			14.4	%		14.8	%		17.9	%		14.5	%
Operating (loss) income from continuing operations			(3.4	%)		(9.6	%)		4.0	%		14.5	%
Net (loss) income from continuing operations			(11.6	%)		(8.4	%)		2.0	%		11.5	%
Income tax rate			(78.0	%)		22.4	%		12.4	%		15.4	%

(1)	Adjusted financial measures are non-GAAP measures and exclude specified items as described and reconciled in the "Reconciliation of GAAP to non-GAAP Financial Measures" contained in the press release.


RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - UNAUDITED (U.S. dollars in millions, except per share amounts)
				Specified Items
Three Months Ended June 30, 2020	GAAP Financial Measures			Merger and Integration Expenses (A)			Restructuring Expenses (B)			Depreciation and Amortization Expenses (C)			Product Remediation Expenses (D)			Financing Transactions (E)			Non-recurring Legal and Contingent Consideration (F)			Stock-based Compensation Costs (G)			Certain Tax Adjustments (H)			Certain Interest Adjustments (I)			Adjusted Financial Measures
Cost of sales - exclusive of amortization	$	56.8		$	—		$	—		$	(0.3)		$	—		$	—		$	15.4		$	(0.3)		$	—		$	—		$	71.6
Product remediation	4.3			—			—			—			(4.3)			—			—			—			—			—			—
Gross profit percent	66.5		%	—		%	—		%	0.2		%	2.3		%	—		%	(8.5)		%	0.2		%	—		%	—		%	60.7		%
Selling, general and administrative	98.0			—			—			(0.1)			—			(2.5)			(6.5)			(9.3)			—			—			79.7
Selling, general and administrative as a percent of net sales	53.8		%	—		%	—		%	—		%	—		%	(1.4)		%	(3.6)		%	(5.1)		%	—		%	—		%	43.7		%
Research and development	25.2			—			—			—			—			—			10.5			(0.4)			—			—			35.2
Research and development as a percent of net sales	13.8		%	—		%	—		%	—		%	—		%	—		%	5.7		%	(0.2)		%	—		%	—		%	19.3		%
Litigation provision, net	1.0			—			—			—			—			—			(1.0)			—			—			—			—
Other operating expenses	12.2			(2.0)			(0.8)			(9.4)			—			—			—			—			—			—			—
Operating loss from continuing operations	(15.2)			2.0			0.8			9.8			4.3			2.5			(18.4)			10.0			—			—			(4.2)
Operating margin percent	(8.4)		%	1.1		%	0.4		%	5.4		%	2.3		%	1.4		%	(10.1)		%	5.5		%	—		%	—		%	(2.3)		%
Income tax expense (benefit)	66.3			—			(0.2)			1.4			0.5			—			0.6			(0.4)			(67.9)			(0.5)			(0.2)
Net loss from continuing operations	(88.0)			2.0			1.0			8.4			3.8			2.7			(19.0)			10.4			67.9			3.3			(7.5)
Diluted EPS - Continuing Operations	$	(1.81)		$	0.04		$	0.02		$	0.17		$	0.08		$	0.05		$	(0.39)		$	0.21		$	1.40		$	0.07		$	(0.15)

GAAP results for the three months ended June 30, 2020 include:

(A)

Merger and integration expenses related to our legacy companies and recent acquisitions

(B)

Restructuring expenses related to organizational changes

(C)

Includes depreciation and amortization associated with purchase price accounting

(D)

Costs related to the 3T Heater-Cooler remediation plan

(E)

Costs associated with our June 2020 financing transactions, including the mark-to-market adjustment for the exchangeable option feature and capped call derivatives

(F)

3T Heater-Cooler litigation provision, legal expenses primarily related to 3T Heater-Cooler defense, settlements and other matters, remeasurement of contingent consideration related to acquisitions

(G)

Non-cash expenses associated with stock-based compensation costs

(H)

Primarily relates to discrete tax items and the tax impact of intercompany transactions

(I)

Primarily relates to non-cash interest expense on our Senior Secured Term Loan and Cash Exchangeable Senior Notes, interest related to the 3T Heater-Cooler matter and intellectual property migration

* Numbers may not add precisely due to rounding.


RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - UNAUDITED (U.S. dollars in millions, except per share amounts)
				Specified Items
Three Months Ended June 30, 2019	GAAP Financial Measures			Merger and Integration Expenses (A)			Restructuring Expenses (B)			Depreciation and Amortization Expenses (C)			Impairments (D)			Product Remediation Expenses (E)			Acquisition Costs (F)			Non-recurring Legal and Contingent Consideration and Other Reserves (G)			Stock-based Compensation Costs (H)			Certain Tax Adjustments (I)			Certain Interest Adjustments (J)			Adjusted Financial Measures
Cost of sales - exclusive of amortization	$	74.9		$	—		$	—		$	(0.7)		$	—		$	—		$	—		$	11.7		$	(0.7)		$	—		$	—		$	85.2
Product remediation	5.1			—			—			—			—			(5.1)			—			—			—			—			—			—
Gross profit percent	71.1		%	—		%	—		%	0.3		%	—		%	1.8		%	—		%	(4.2)		%	0.3		%	—		%	—		%	69.3		%
Selling, general and administrative	127.2			—			—			(0.1)			—			—			(0.3)			(12.4)			(6.3)			—			—			108.1
Selling, general and administrative as a percent of net sales	45.9		%	—		%	—		%	—		%	—		%	—		%	(0.1)		%	(4.5)		%	(2.3)		%	—		%	—		%	39.0		%
Research and development	34.5			—			—			(0.1)			(0.9)			—			(0.2)			7.9			(1.7)			—			—			39.7
Research and development as a percent of net sales	12.5		%	—		%	—		%	—		%	(0.3)		%	—		%	(0.1)		%	2.9		%	(0.6)		%	—		%	—		%	14.3		%
Other operating expenses	65.2			(4.4)			(1.3)			(9.2)			(50.3)			—			—			—			—			—			—			—
Operating (loss) income from continuing operations	(29.9)			4.4			1.3			10.1			51.2			5.1			0.5			(7.3)			8.7			—			—			44.2
Operating margin percent	(10.8)		%	1.6		%	0.5		%	3.7		%	18.5		%	1.8		%	0.2		%	(2.6)		%	3.1		%	—		%	—		%	15.9		%
Income tax (benefit) expense	(6.2)			1.1			0.4			2.6			12.4			1.7			0.1			2.3			2.0			(10.6)			0.4			6.2
Net (loss) income from continuing operations	(29.4)			3.3			1.0			7.5			38.8			3.4			0.4			(9.6)			6.7			10.6			1.6			34.3
Diluted EPS - Continuing Operations	$	(0.61)		$	0.07		$	0.02		$	0.15		$	0.80		$	0.07		$	0.01		$	(0.20)		$	0.14		$	0.22		$	0.03		$	0.70

GAAP results for the three months ended June 30, 2019 include:

(A)

Merger and integration expenses related to our legacy companies and recent acquisitions

(B)

Restructuring expenses related to organizational changes

(C)

Includes depreciation and amortization associated with purchase price accounting

(D)

Impairment of ImThera intangible assets and other long-lived assets

(E)

Costs related to the 3T Heater-Cooler remediation plan

(F)

Costs related to acquisitions

(G)

Contingent consideration related to acquisitions and legal expenses primarily related to 3T Heater-Cooler defense and other matters

(H)

Non-cash expenses associated with stock-based compensation costs

(I)

Primarily relates to discrete tax items and the tax impact of intercompany transactions

(J)

Primarily relates to intellectual property migration and other non-recurring impacts to interest expense

* Numbers may not add up precisely due to rounding.


RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - UNAUDITED (U.S. dollars in millions, except per share amounts)
				Specified Items
Six Months Ended June 30, 2020	GAAP Financial Measures			Merger and Integration Expenses (A)			Restructuring Expenses (B)			Depreciation and Amortization Expenses (C)			Product Remediation Expenses (D)			Financing Transactions (E)			Non-recurring Legal and Contingent Consideration (F)			Stock-based Compensation Costs (G)			Certain Tax Adjustments (H)			Certain Interest Adjustments (I)			Adjusted Financial Measures
Cost of sales - exclusive of amortization	$	125.7		$	—		$	—		$	(0.7)		$	—		$	—		$	24.2		$	(0.9)		$	—		$	—		$	148.3
Product remediation	5.7			—			—			—			(5.7)			—			—			—			—			—			—
Gross profit percent	69.0		%	—		%	—		%	0.2		%	1.4		%	—		%	(5.7)		%	0.2		%	—		%	—		%	65.1		%
Selling, general and administrative	218.2			—			—			(0.1)			—			(2.5)			(15.6)			(16.6)			—			—			183.4
Selling, general and administrative as a percent of net sales	51.4		%	—		%	—		%	—		%	—		%	(0.6)		%	(3.7)		%	(3.9)		%	—		%	—		%	43.2		%
Research and development	61.1			—			—			(0.1)			—			—			16.6			(1.5)			—			—			76.1
Research and development as a percent of net sales	14.4		%	—		%	—		%	—		%	—		%	—		%	3.9		%	(0.4)		%	—		%	—		%	17.9		%
Litigation provision, net	1.0			—			—			—			—			—			(1.0)			—			—			—			—
Other operating expenses	27.6			(5.5)			(2.4)			(19.7)			—			—			—			—			—			—			—
Operating (loss) income from continuing operations	(14.6)			5.5			2.4			20.5			5.7			2.5			(24.3)			19.0			—			—			16.8
Operating margin percent	(3.4)		%	1.3		%	0.6		%	4.8		%	1.4		%	0.6		%	(5.7)		%	4.5		%	—		%	—		%	4.0		%
Income tax expense	21.6			0.3			—			2.9			0.8			—			2.0			0.6			(27.0)			—			1.2
Net (loss) income from continuing operations	(49.4)			5.2			2.4			17.6			5.0			2.7			(26.3)			18.4			27.0			6.0			8.5
Diluted EPS - Continuing Operations	$	(1.02)		$	0.11		$	0.05		$	0.36		$	0.10		$	0.05		$	(0.54)		$	0.38		$	0.55		$	0.12		$	0.17

GAAP results for the six months ended June 30, 2020 include:

(A)

Merger and integration expenses related to our legacy companies and recent acquisitions

(B)

Restructuring expenses related to organizational changes

(C)

Includes depreciation and amortization associated with purchase price accounting

(D)

Costs related to the 3T Heater-Cooler remediation plan

(E)

Costs associated with our June 2020 financing transactions, including the mark-to-market adjustment for the exchangeable option feature and capped call derivatives

(F)

3T Heater-Cooler litigation provision, legal expenses primarily related to 3T Heater-Cooler defense, settlements and other matters, remeasurement of contingent consideration related to acquisitions

(G)

Non-cash expenses associated with stock-based compensation costs

(H)

Primarily relates to discrete tax items and the tax impact of intercompany transactions

(I)

Primarily relates to non-cash interest expense on our Senior Secured Term Loan and Cash Exchangeable Senior Notes, interest related to the 3T Heater-Cooler matter and intellectual property migration

* Numbers may not add precisely due to rounding.


RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - UNAUDITED (U.S. dollars in millions, except per share amounts)
				Specified Items
Six Months Ended June 30, 2019	GAAP Financial Measures			Merger and Integration Expenses (A)			Restructuring Expenses (B)			Depreciation and Amortization Expenses (C)			Impairments (D)			Product Remediation Expenses (E)			Acquisition Costs (F)			Non-recurring Legal and Contingent Consideration and Other Reserves (G)			Stock-based Compensation Costs (H)			Certain Tax Adjustments (I)			Certain Interest Adjustments (J)			Adjusted Financial Measures
Cost of sales - exclusive of amortization	$	159.2		$	—		$	—		$	(1.4)		$	—		$	—		$	—		$	5.5		$	(1.0)		$	—		$	—		$	162.3
Product remediation	8.1			—			—			—			—			(8.1)			—			—			—			—			—			—
Gross profit percent	68.3		%	—		%	—		%	0.3		%	—		%	1.5		%	—		%	(1.0)		%	0.2		%	—		%	—		%	69.3		%
Selling, general and administrative	252.9			—			—			(0.3)			—			—			(0.7)			(27.8)			(11.6)			—			—			212.6
Selling, general and administrative as a percent of net sales	47.9		%	—		%	—		%	(0.1)		%	—		%	—		%	(0.1)		%	(5.3)		%	(2.2)		%	—		%	—		%	40.3		%
Research and development	78.1			—			—			(0.1)			(0.9)			—			(1.9)			4.2			(2.9)			—			—			76.5
Research and development as a percent of net sales	14.8		%	—		%	—		%	—		%	(0.2)		%	—		%	(0.4)		%	0.8		%	(0.6)		%	—		%	—		%	14.5		%
Other operating expenses	80.3			(7.6)			(3.9)			(18.5)			(50.3)			—			—			—			—			—			—			—
Operating (loss) income from continuing operations	(50.7)			7.6			3.9			20.3			51.2			8.1			2.6			18.0			15.6			—			—			76.6
Operating margin percent	(9.6)		%	1.4		%	0.7		%	3.8		%	9.7		%	1.5		%	0.5		%	3.4		%	3.0		%	—		%	—		%	14.5		%
Income tax (benefit) expense	(12.8)			1.7			0.9			5.2			12.4			2.6			0.6			9.5			3.6			(13.0)			0.3			11.1
Net (loss) income from continuing operations	(44.2)			5.9			2.9			15.2			38.8			5.4			2.0			8.5			12.0			13.0			1.3			60.9
Diluted EPS - Continuing Operations	$	(0.92)		$	0.12		$	0.06		$	0.31		$	0.79		$	0.11		$	0.04		$	0.17		$	0.25		$	0.27		$	0.03		$	1.25

GAAP results for the six months ended June 30, 2019 include:

(A)

Merger and integration expenses related to our legacy companies and recent acquisitions

(B)

Restructuring expenses related to organizational changes

(C)

Includes depreciation and amortization associated with purchase price accounting

(D)

Impairment of ImThera intangible assets and other long-lived assets

(E)

Costs related to the 3T Heater-Cooler remediation plan

(F)

Costs related to acquisitions

(G)

Contingent consideration related to acquisitions and legal expenses primarily related to 3T Heater-Cooler defense and other matters

(H)

Non-cash expenses associated with stock-based compensation costs

(I)

Primarily relates to discrete tax items and the tax impact of intercompany transactions

(J)

Primarily relates to intellectual property migration and other non-recurring impacts to interest expense

* Numbers may not add up precisely due to rounding.


LIVANOVA PLC AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED
(U.S. dollars in millions)
	June 30, 2020	December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$232.5	$61.1
Accounts receivable, net of allowance	186.1	257.8
Inventories, net	177.2	164.2
Prepaid and refundable taxes	41.7	37.8
Prepaid expenses and other current assets	34.8	28.6
Total Current Assets	672.4	549.4
Property, plant and equipment, net	185.7	181.4
Goodwill	902.2	915.8
Intangible assets, net	583.5	607.5
Operating lease assets	51.1	54.4
Investments	30.2	27.3
Deferred tax assets	23.1	68.7
Other assets	54.4	7.4
Total Assets	$2,502.7	$2,411.8

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current debt obligations	$7.4	$77.4
Accounts payable	69.1	85.9
Accrued liabilities and other	97.2	120.1
Current litigation provision liability	37.4	146.0
Taxes payable	8.4	12.7
Accrued employee compensation and related benefits	48.8	70.4
Total Current Liabilities	268.4	512.6
Long-term debt obligations	639.2	260.3
Contingent consideration	71.2	114.4
Litigation provision liability	11.6	24.4
Deferred tax liabilities	30.1	32.2
Long-term operating lease liabilities	42.4	46.0
Long-term employee compensation and related benefits	22.4	22.8
Long-term derivative liability	71.5	0.1
Other long-term liabilities	12.7	15.3
Total Liabilities	1,169.5	1,028.1
Total Stockholders’ Equity	1,333.2	1,383.7
Total Liabilities and Stockholders’ Equity	$2,502.7	$2,411.8

* Numbers may not add up precisely due to rounding.


LIVANOVA PLC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED
(U.S. dollars in millions)	Six Months Ended June 30,
	2020	2019
Operating Activities:
Net loss	($50.4)	($44.1)
Non-cash items included in net loss:
Deferred tax expense	46.2	15.9
Remeasurement of contingent consideration to fair value	(46.0)	(10.6)
Amortization	19.7	18.5
Stock-based compensation	19.0	15.6
Depreciation	13.6	15.3
Remeasurement of derivative instruments	(7.3)	(3.8)
Amortization of operating lease assets	6.3	6.3

Impairment of intangible assets	—	50.3

Other	5.4	5.9
Changes in operating assets and liabilities:
Accounts receivable, net	66.3	(0.3)
Inventories, net	(16.2)	(14.3)
Other current and non-current assets	(10.3)	5.3
Accounts payable and accrued current and non-current liabilities	(47.1)	(29.1)
Taxes payable	(2.2)	(43.0)
Litigation provision liability	(121.2)	—
Restructuring reserve	(0.9)	(5.5)
Net cash used in operating activities	(125.1)	(17.4)
Investing Activities:
Purchases of property, plant and equipment	(18.0)	(10.8)
Purchase of investments	(3.2)	(0.3)
Loans to investees	(2.3)	—
Acquisitions, net of cash acquired	—	(10.8)


Other	0.7	(0.6)
Net cash used in investing activities	(22.7)	(22.5)
Financing Activities:
Proceeds from long-term debt obligations	886.9	53.8
Repayment of long-term debt obligations	(481.3)	(12.1)
Proceeds from short term borrowings (maturities greater than 90 days)	46.7	—
Repayments of short term borrowings (maturities greater than 90 days)	(44.8)	—
Purchase of capped call	(43.1)	—
Debt issuance costs	(20.0)	(3.7)
Closing adjustment payment for sale of CRM business	(14.9)	—
Payment of contingent consideration	(5.3)	(0.3)
Shares repurchased from employees for minimum tax withholding	(5.2)	(5.7)
Proceeds from share issuances under ESPP	2.1	2.6
Change in short-term borrowing, net	(1.5)	2.4

Other	—	0.2
Net cash provided by financing activities	319.7	37.1
Effect of exchange rate changes on cash and cash equivalents	(0.6)	0.1
Net increase (decrease) in cash and cash equivalents	171.4	(2.7)
Cash and cash equivalents at beginning of period	61.1	47.2
Cash and cash equivalents at end of period	$232.5	$44.5

* Numbers may not add up precisely due to rounding.

The following table presents the reconciliation of GAAP diluted weighted average shares outstanding, used in the computation of GAAP diluted net loss per common share from continuing operations, to adjusted diluted weighted average shares outstanding, used in the computation of adjusted diluted earnings per common share from continuing operations (in millions of shares):


		Three Months Ended June 30, 2019		Six Months Ended June 30,
					2020	2019
GAAP diluted weighted average shares outstanding			48.3		48.5	48.3
Add effects of stock-based compensation instruments			0.4		0.3	0.5
Adjusted diluted weighted average shares outstanding ⁽¹⁾			48.7		48.8	48.8

(1)	Adjusted diluted weighted average shares outstanding is a non-GAAP measure and includes the effects of stock-based compensation instruments, as reconciled in the above table.
*	Numbers may not add up precisely due to rounding.

EX-101.SCH 3 livn-20200729.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 livn-20200729_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 livn-20200729_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 livn-20200729_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Entity Address, Country Entity Address, Country Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Country Region Country Region EX-101.PRE 7 livn-20200729_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 downloada0311.jpg begin 644 downloada0311.jpg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end GRAPHIC 9 livn-20200729_g1.jpg begin 644 livn-20200729_g1.jpg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end XML 10 livn-20200729_htm.xml IDEA: XBRL DOCUMENT 0001639691 2020-07-29 2020-07-29 LIVANOVA PLC 0001639691 false 8-K 2020-07-29 X0 001-37599 98-1268150 20 Eastbourne Terrace London W2 6LG GB 44 20 33250660 false false false false Ordinary Shares - £1.00 par value per share LIVN NASDAQ false XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2

Document and Entity Information Document

Jul. 29, 2020

Cover [Abstract]

Document Type 8-K

Document Period End Date Jul. 29, 2020

Entity Incorporation, State or Country Code X0

Entity File Number 001-37599

Entity Tax Identification Number 98-1268150

Entity Address, Address Line One 20 Eastbourne Terrace

Entity Address, City or Town London

Entity Address, Postal Zip Code W2 6LG

Entity Address, Country GB

Country Region 44

City Area Code 20

Local Phone Number 33250660

Written Communications false

Soliciting Material false

Pre-commencement Tender Offer false

Pre-commencement Issuer Tender Offer false

Title of 12(b) Security Ordinary Shares - £1.00 par value per share

Trading Symbol LIVN

Security Exchange Name NASDAQ

Entity Emerging Growth Company false

Entity Registrant Name LIVANOVA PLC

Entity Central Index Key 0001639691

Amendment Flag false

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Region code of country
+ References
No definition available.
+ Details

Name: dei_CountryRegion

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cover page.
+ References
No definition available.
+ Details

Name: dei_CoverAbstract

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
ISO 3166-1 alpha-2 country code.
+ References
No definition available.
+ Details

Name: dei_EntityAddressCountry

Namespace Prefix: dei_

Data Type: dei:countryCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details

Name: dei_PreCommencementIssuerTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details

Name: dei_PreCommencementTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
+ Details

Name: dei_SolicitingMaterial

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details

Name: dei_WrittenCommunications

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( *0P_5 '04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "D,/U0@9?PK.\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M:L,P#(=?9?B>R$E9RTR:RT9/'0Q6V-C-V&IK&O_!UDCZ]G.R-F5L#["CI9\_ M?0(U*@CE([Y$'S"2P70WV,XEH<*:'8F" $CJB%:F,B=<;NY]M)+R,QX@2'62 M!X2:\R58)*DE21B!19B)K&VT$BJB)!\O>*UF?/B,W033"K!#BXX25&4%K!TG MAO/0-7 #C##":--W ?5,G*I_8J<.L$MR2&9.]7U?]HLIEW>HX/UY^SJM6QB7 M2#J%^5&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" "D,/U02-^;TTH$ #1$ & 'AL+W=O_0D-G.NU,$MOB([ ES! V2>FR"0TTZ;33"V$+T*PMN9(< MDG_?(V/LM#7'26^P94NO'YTCO9(8[I3^:K:<6_*^(3'L5,"CK\*T5;Y M3=?P]?U!_3KO/'1FQ0R?J/A11'9[T>JW2,37+(OMO=K]Q(L.Y8"ABDW^2W;[ MNIU.BX29L2HI&@-!(N3^RIZ+0+RE 2T:T)Q[_Z&<\A.S;#34:D>TJPUJ[B;O M:MX:X(1T65E8#6\%M+.C3RK,(,B6,!F1*VF%?2%3N<^VB]KA_="S\#77Q@L+ MYNTC>A/UQ#7Y8[PR5D,N_T0D MVZ5D.Y?L-'5^^9+RNA[BS?NGGQ&(3@G1>1O$G&NA7!(B JFLY<&5#A'_YL.' MAIAW2[8NJE@.B%#I5.E\2)R0A04\HC29J$Q:_0+7J!87%_\-(^R5A+VW$%Z+ MF)/;+%EQ70>":_A^<-H^[PX&",]YR7/^%IXE>R;3"+(JUB+13EP)QMQ2[60=):XV4S)2$L$*_,HP_7>!S96Q+":_B_3H/&A0?*2D M-[O!X%ZY>?"^J.UG:"T4KG1SB0%5IAU05.9@$?=\(_Z=@((#%^AT,([*Z0/< MJ_/A,X9]R_$DX0*HGP:5V0>X1\]4"(-EOE42\ZL&D7:;=OU>#R6J+#[ ;?A1 M"VNYA+@D228+MS*U5+C0FL4&F_E!Y>D!;L@+%8M06"$WY LL-5JPN)8'5VGD MJ3P]P"UXKOEI".'A,N3[_0*7$6Q&[M;K(_G#]1K)*CL/ZTY&0<' @BRT#/>7*PV5PG7&Q>E M&U"P6^:6'7=>@)EQ-%RX$"1P?'OW,";SV00C MJU8 BIMW03:!V:IA*9C"1'TFGWE]N' I'W:NO?:@-P@PLFHEH+B!C\%!HMQ% MKF.VJ>7YGRN ]^J Z@[[7Y@;,(;$? U"_MDYZ.K]^7E?L"K-SZPK9>$$G-]N M.0-+RBX8W#Y+\;H;U!+ P04 " "D,/U0@ZFE ]0! R!@ M#0 'AL+W-T>6QE1'9!20(J+ @J"SL/OG:2 M2M+0-SN5,=FOMSN=V[@,J ^B+Y,ZIZI/G;Y.UN,DX:D#0#(JJ?N<=HCV+6-] MU8'B_2MC0?M,8YSBZ*%K66\=\+H/@Y1DZ>ETSQ07FA:9'M2#PIY49M"8TQ-E M1=88O3.O:21\*5= +ESF] .7HG1BKN5*R"G2:2 J(XTCZ*U 3I/ ],\QG404 M7"XZ2FCC LEBA_A;+N4_)5;4>RBDW RF-!)%9CDB./W@P5P\DR]29(G/D_4. M6\>G)+VC^X#YXYN4QM7@MC8)7:DBD] $.TZT7?BBL2PD$8WR02UX:S2?/:PC MEL#+5B#E4]C"K\V5]MB0N!_9$LL>)B M\/W@9Z-G_&TP"(\.&C'.>&RV_K?4D]OJW%HYO9.BU0KBW'^Y89'Q=1SIC!// MOELX*94GP%%R 8>B.C+?';=G&'$]36-SVW/Z'WK^N^O<@@;'Y=&T/_K_\BK_ MCF.VW)[#%;VZH!M+PD.8TR_A?96[!U(.0J+0"^I$78-^<4^]//+2/^!7^KZ^ MAH8/$L];,J=[_!EJ,:@W6]5C6)>E:H\_A?*NQS $P( L !?3T\$MP>:4#M.*2VBZD8_1!2 M:5K5N %(MB6/:(7->= MI3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8 M%II%R=.B':5_'FR- M9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X3[+O,&@EXN1:T/9=1,92L88!.R '<(Y_A^[<#K3P&]'@! M6^AC(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&% ME+C?Z/F-:#R!+ ]=R_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$ M52Q;#X&'' E<)S"D&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI# MFJ,,:&T'X:-:"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W M_ %02P,$% @ I##]4"0>FZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB M688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4: MY$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[? M#'!X=/X!4$L#!!0 ( *0P_5!ED'F2&0$ ,\# 3 6T-O;G1E;G1? M5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS M3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV M(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U M2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z M6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1 M.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( *0P M_5!(WYO32@0 -$0 8 " @0X( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M" "D,/U099!YDAD! #/ P $P @ ''$0 6T-O;G1E;G1? @5'EP97-=+GAM;%!+!08 "0 ) #X" 1$P ! end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports livn-20200729.htm a2q20earningspressrele.htm livn-20200729.xsd livn-20200729_cal.xml livn-20200729_def.xml livn-20200729_lab.xml livn-20200729_pre.xml livn-20200729_g1.jpg http://xbrl.sec.gov/dei/2019-01-31 true true JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "livn-20200729.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "livn-20200729_cal.xml" ] }, "definitionLink": { "local": [ "livn-20200729_def.xml" ] }, "inline": { "local": [ "livn-20200729.htm" ] }, "labelLink": { "local": [ "livn-20200729_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "livn-20200729_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "livn-20200729.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "livn", "nsuri": "http://www.livanova.cyberonics.com/20200729", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "livn-20200729.htm", "contextRef": "if6d23ab31eef4d2a8e7ed51c75226d3c_D20200729-20200729", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "livn-20200729.htm", "contextRef": "if6d23ab31eef4d2a8e7ed51c75226d3c_D20200729-20200729", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.livanova.cyberonics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 19 0001639691-20-000093-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001639691-20-000093-xbrl.zip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end

Document and Entity Information Document	Jul. 29, 2020
Cover [Abstract]
Document Type	8-K
Document Period End Date	Jul. 29, 2020
Entity Incorporation, State or Country Code	X0
Entity File Number	001-37599
Entity Tax Identification Number	98-1268150
Entity Address, Address Line One	20 Eastbourne Terrace
Entity Address, City or Town	London
Entity Address, Postal Zip Code	W2 6LG
Entity Address, Country	GB
Country Region	44
City Area Code	20
Local Phone Number	33250660
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Ordinary Shares - £1.00 par value per share
Trading Symbol	LIVN
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Entity Registrant Name	LIVANOVA PLC
Entity Central Index Key	0001639691
Amendment Flag	false